ICU Medical, Inc. (NASDAQ:ICUI) Sees Large Decline in Short Interest

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) was the target of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 652,500 shares, a decrease of 7.2% from the October 15th total of 703,400 shares. Approximately 2.9% of the shares of the company are short sold. Based on an average daily volume of 253,400 shares, the days-to-cover ratio is currently 2.6 days.

ICU Medical Price Performance

Shares of ICUI stock traded up $2.26 during trading hours on Monday, hitting $170.12. 135,022 shares of the company's stock were exchanged, compared to its average volume of 274,924. The stock's 50-day moving average is $176.43 and its 200-day moving average is $143.31. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.08. The stock has a market cap of $4.16 billion, a price-to-earnings ratio of -36.73 and a beta of 0.66. ICU Medical has a 52 week low of $82.82 and a 52 week high of $196.26.

Analysts Set New Price Targets

A number of brokerages have weighed in on ICUI. Jefferies Financial Group began coverage on ICU Medical in a research report on Monday, October 14th. They issued a "hold" rating and a $183.00 price target on the stock. KeyCorp upped their price target on ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday, November 13th. StockNews.com cut ICU Medical from a "buy" rating to a "hold" rating in a research report on Tuesday, November 12th. Raymond James upped their price target on ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $173.00.

Insider Activity at ICU Medical

In related news, VP Daniel Woolson sold 2,502 shares of the company's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $163.22, for a total value of $408,376.44. Following the completion of the transaction, the vice president now directly owns 13,107 shares in the company, valued at approximately $2,139,324.54. This represents a 16.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of the company's stock in a transaction on Friday, November 1st. The shares were sold at an average price of $171.84, for a total value of $2,062,080.00. Following the completion of the transaction, the chief executive officer now owns 104,593 shares of the company's stock, valued at $17,973,261.12. The trade was a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 38,502 shares of company stock worth $6,573,496. 6.70% of the stock is owned by corporate insiders.

Institutional Trading of ICU Medical

Several large investors have recently made changes to their positions in ICUI. Innealta Capital LLC bought a new stake in shares of ICU Medical during the second quarter worth $32,000. Hexagon Capital Partners LLC grew its holdings in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock worth $36,000 after buying an additional 122 shares in the last quarter. Allworth Financial LP grew its stake in ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. EntryPoint Capital LLC grew its stake in ICU Medical by 731.5% in the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier's stock valued at $48,000 after purchasing an additional 395 shares in the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in shares of ICU Medical by 46.4% during the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier's stock worth $59,000 after acquiring an additional 173 shares during the period. Institutional investors own 96.10% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.